Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,110 | -3,501 | -316 | -1 | -2 |
| Accounts receivable | N/A | -550 | N/A | 2 | N/A |
| Accounts payable and accrued liabilities | N/A | -300 | N/A | N/A | N/A |
| Other Working Capital | 9,681 | 2,627 | 315 | 4 | 2 |
| Other Operating Activity | 0 | 850 | 0 | -2 | 0 |
| Operating Cash Flow | $-429 | $-874 | $-1 | $2 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 949 | N/A | N/A |
| Other Financing Activity | 307 | 303 | 47 | 0 | 0 |
| Financing Cash Flow | $307 | $303 | $996 | $N/A | $N/A |
| Beginning Cash Position | 995 | 995 | N/A | N/A | N/A |
| End Cash Position | 873 | 424 | 995 | 2 | N/A |
| Net Cash Flow | $-122 | $-571 | $995 | $2 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -429 | -874 | -1 | 2 | N/A |
| Free Cash Flow | -429 | -874 | -1 | 2 | 0 |